Osteosarcoma as a communication-driven disease: redefining tumor-bone signaling networks as therapeutic targets

Gabriele Ricciardi1,2, Vincenzo Fiorentino1,3, Pietro Tralongo1

  • 1BIOMORF Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, A.O.U. Policlinico "G.Martino"- Via Consolare Valeria 1, Messina, Italy.

Frontiers in Oncology
|August 6, 2026
PubMed

Insights

Osteosarcoma (OS) is a communication-driven bone cancer. Targeting intercellular signaling networks in the tumor microenvironment offers new therapeutic strategies for this aggressive disease.

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment

Background:

  • Osteosarcoma (OS) is an aggressive bone cancer with high metastatic potential.
  • Genomic instability alone doesn't explain OS; intercellular communication is key.
  • The tumor microenvironment significantly influences OS progression and treatment resistance.

Purpose of the Study:

  • To review the role of intercellular communication in Osteosarcoma.
  • To integrate knowledge on signaling networks within the OS tumor microenvironment.
  • To identify novel therapeutic vulnerabilities by framing OS as a communication-driven ecosystem.

Main Methods:

  • Literature review integrating current knowledge on OS signaling.
  • Analysis of immune cell crosstalk, extracellular vesicles, soluble factors, and direct cell-cell interactions.
  • Discussion of how communication circuits shape the tumor immune microenvironment and plasticity.

Main Results:

  • Intercellular signaling networks critically regulate OS growth, immune evasion, metastasis, and therapy resistance.
  • Communication circuits coordinate local and systemic tumor progression.
  • These networks shape the tumor immune microenvironment and drive adaptive plasticity.

Conclusions:

  • Osteosarcoma progression is heavily influenced by complex intercellular communication.
  • Disrupting these pathological signaling networks presents emerging therapeutic strategies.
  • Further clinical validation is needed for many communication-targeted approaches in OS.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...